Clinical Trial Update: Antiarrhythmic and Cardioprotective Effects of Atorvastatin Versus Magnesium Sulfate in Cardiac Valve Replacement Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating antiarrhythmic and cardioprotective effects of atorvastatin versus magnesium sulfate in cardiac valve replacement surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmias

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Assiut University | Conditions: Arrhythmias | Phase 4 | Status: UNKNOWN